Kim E Zerba

Title: Kim E Zerba: Innovator in Cardiovascular Genetics

Introduction

Kim E Zerba is a notable inventor based in New Hope, PA (US). He has made significant contributions to the field of genetics, particularly in understanding cardiovascular disorders. With a total of 3 patents, his work has implications for both medical research and treatment.

Latest Patents

Zerba's latest patents focus on genetic polymorphisms associated with cardiovascular disorders and drug response. These inventions are based on the discovery of genetic variations linked to acute coronary events, such as myocardial infarction and stroke. His work also explores how these polymorphisms affect an individual's response to statin treatment for cardiovascular disorders. The patents detail nucleic acid molecules containing these polymorphisms, variant proteins encoded by them, and methods for detecting these genetic markers.

Career Highlights

Throughout his career, Kim E Zerba has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Celera Corporation and Bristol-Myers Squibb Company, where he contributed to groundbreaking research and development in genetics and drug response.

Collaborations

Zerba has collaborated with notable colleagues, including Olga Iakoubova and James J Devlin. These partnerships have furthered his research and expanded the impact of his inventions in the field of cardiovascular genetics.

Conclusion

Kim E Zerba's innovative work in genetic polymorphisms has the potential to transform the understanding and treatment of cardiovascular disorders. His contributions continue to influence the medical community and improve patient outcomes.